Trials / Completed
CompletedNCT02892110
Varenicline Treatment for Cannabis Use Disorder
Advancing Varenicline as a Treatment for Cannabis Use Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Marijuana is the most commonly used illicit drug. There is high demand for effective interventions for cannabis use disorder, yet few specific treatments for have been developed. This study will evaluate the efficacy of varenicline for reducing marijuana use in people who use marijuana frequently.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Varenicline | 2 mg daily |
| DRUG | Placebo | 2 mg daily |
Timeline
- Start date
- 2017-02-13
- Primary completion
- 2018-11-08
- Completion
- 2018-11-27
- First posted
- 2016-09-08
- Last updated
- 2019-12-03
- Results posted
- 2019-12-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02892110. Inclusion in this directory is not an endorsement.